#53561
Re: Farmas USA
Xq ultimamente no deja de haber news los lunes.
NVAX
edito: y fijate en semanal que rica velica
Se está hablando de:
#53562
Re: Farmas USA
Siiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii, jajaja
nvax
#53563
Re: Farmas USA
Rica rica, y el IBB en la semana -0.68% NVAX +6.67%, eso también queda bonito :)
NVAX
#53564
Re: Farmas USA
Confirmado el veredicto del juez AMRN vs AZN
http://investor.amarincorp.com/secfiling.cfm?filingid=1193125-14-413357&CIK=897448
On November 14, 2014, based on a representation from AstraZeneca Pharmaceuticals LP that the commercial launch of Epanova™ in the United States is not imminent, the United States District Court for the District of Delaware dismissed, without prejudice ( i.e. , preserving the ability for Amarin to later re-file the suit), Amarin’s complaint against Omthera Pharmaceuticals, Inc., and its parent company, AstraZeneca Pharmaceuticals LP. The complaint sought injunctive relief and monetary damages for infringement of Amarin’s U.S. Patent No. 8,663,662 (the “Patent”). In the complaint, Amarin alleged infringement of the Patent arising from the anticipated launch of Epanova TM in the United States following the product’s FDA approval in May 2014. The court found that for the case to proceed, the launch of Epanova must be imminent. The court was persuaded by the defendants’ representation that Epanova™ would not be launched in 2014 and by the defendants’ representation that it would provide notice to Amarin prior to any product launch. The court indicated that it relied on those representations in rendering its decision and noted that they are binding on the defendants as a matter of judicial estoppel. Amarin intends to pursue this litigation vigorously if and when any such notice is received and plans to aggressively protect its intellectual property rights.
-----------------------------------
Ahora lo que se pregunta el pueblo es : vamosa ver, Epanova tenia previsto ser lanzada al mercado en Q4 2014 ... como que el lanzamiento no es inminente? Porque se retrasa? Algun problema con proveedores? O negociaciones bajo mesa?
AMRN
#53565
Re: Farmas USA
Vamos a tener teorias varias estos dias my friend!.
#53566
Re: Farmas USA
Google finance indica 23% de institucionales ... y ese ha sido mi valor de referencia estos dias.
Nasdaq.com indica hoy 49% ... de ser cierto es tremendo!
SNTA
#53567
Re: Farmas USA
Snta
Finviz da también un 23% pero lo que es un escándalo es la pinta que tiene el semanal de cara a la conferencia de la semana que viene. Que buena pinta!
#53568